doi: 10.1001/jama.2021.23619
Thank you for all your hard work to all the people working on our case
An overview of once-weekly glucagon-like peptide-1 receptor agonists - available efficacy and safety data and perspectives for the future
The litigation involves allegations that Ozempic (semaglutide), a medication prescribed for diabetes and weight loss, caused serious gastrointestinal injuries, including pancreatitis and other related complications
doi:10.1111/obr.12839 5
How to build a list : Offer a lead magnet: Free Guide: 10 Questions to Ask Your Doctor About GLP-1 Medications in exchange for email signup Pop-up on your website: Get weight-loss tips from a psychiatristjoin 500+ subscribers Capture emails from initial inquiries (with permission) What to send : Welcome sequence (3-5 emails): Introduce yourself, share your approach, address common concerns, make booking easy Weekly or biweekly newsletter: Quick tips, answer one FAQ, share a recent blog post, patient success snippet Re-engagement campaign: For people who inquired but didnt bookStill considering weight-loss treatment
